Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Aliskiren/amlodipine/hydrochlorothiazide
Подписчиков: 0, рейтинг: 0
Combination of | |
---|---|
Aliskiren | Renin inhibitor |
Amlodipine | Calcium channel blocker |
Hydrochlorothiazide | Diuretic |
Clinical data | |
Trade names | Amturnide |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
License data | |
Routes of administration |
By mouth |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
PubChem CID | |
KEGG |
|
Chemical and physical data | |
Formula | C57H86Cl2N8O15S2 |
Molar mass | 1258.38 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Aliskiren/amlodipine/hydrochlorothiazide, sold under the brand name Amturnide, is a fixed-dose combination medication that is used to treat high blood pressure. It contains aliskiren, amlodipine, and hydrochlorothiazide. It is taken by mouth.
It was approved for medical use in the United States in December 2010. Amturnide was withdrawn by Novartis from the US market in 2017.
External links
- "Aliskiren mixture with amlodipine and hydrochlorothiazide". Drug Information Portal. U.S. National Library of Medicine.
- "FDA Drug Safety Communication: New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna)". U.S. Food and Drug Administration (FDA). 29 June 2021.
ACE inhibitors ("-pril") |
|
---|---|
AIIRAs ("-sartan") |
|
Renin inhibitors ("-kiren") |
|
Dual ACE/NEP inhibitors | |
Neprilysin inhibitors | |
|
Sulfonamides (and etacrynic acid) |
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Potassium-sparing (at CD) |
|
||||||||
Osmotic diuretics (PT, DL) | |||||||||
Vasopressin receptor inhibitors (DCT and CD) |
|||||||||
Other | |||||||||
Combination products | |||||||||
|